Varian Medical Systems, Inc. (VAR) EPS Estimated At $1.03

April 24, 2018 - By Adrian Mccoy

Varian Medical Systems, Inc. (NYSE:VAR) LogoInvestors sentiment decreased to 0.8 in Q4 2017. Its down 0.22, from 1.02 in 2017Q3. It is negative, as 37 investors sold Varian Medical Systems, Inc. shares while 194 reduced holdings. 63 funds opened positions while 122 raised stakes. 87.00 million shares or 3.31% less from 89.98 million shares in 2017Q3 were reported.
Virginia-based Bb&T Secs Ltd Limited Liability Company has invested 0.02% in Varian Medical Systems, Inc. (NYSE:VAR). Stone Run Capital Ltd Liability Co invested in 0.46% or 8,135 shares. Vanguard Grp holds 9.30M shares or 0.05% of its portfolio. 493 were reported by Peak6 Invs L P. Teacher Retirement System Of Texas invested 0.02% in Varian Medical Systems, Inc. (NYSE:VAR). Teachers Retirement Of The State Of Kentucky, a Kentucky-based fund reported 41,407 shares. Security Natl Trust Communications holds 0.29% or 8,000 shares. Fund Evaluation Group Ltd has invested 0.29% in Varian Medical Systems, Inc. (NYSE:VAR). Grassi Inv reported 0.05% stake. Cranbrook Wealth Mngmt Limited Co accumulated 160 shares. Gw Henssler And Associate stated it has 0.07% in Varian Medical Systems, Inc. (NYSE:VAR). Chicago Equity Prtn Ltd Liability Corp reported 23,740 shares. Martingale Asset Mgmt Limited Partnership reported 92,228 shares or 0.14% of all its holdings. Commonwealth Of Pennsylvania Public School Empls Retrmt System has invested 0.01% in Varian Medical Systems, Inc. (NYSE:VAR). Fagan Assocs reported 0.18% stake.

Since December 12, 2017, it had 0 insider purchases, and 20 selling transactions for $22.34 million activity. $84,113 worth of Varian Medical Systems, Inc. (NYSE:VAR) was sold by KENNEDY KOLLEEN T. Another trade for 1,556 shares valued at $196,792 was made by MOMSEN MAGNUS on Monday, March 12. The insider LARET MARK R sold $274,383. $93,575 worth of Varian Medical Systems, Inc. (NYSE:VAR) shares were sold by KUO JOHN W. $3.04 million worth of Varian Medical Systems, Inc. (NYSE:VAR) was sold by WILSON DOW R. ILLINGWORTH DAVID J sold $692,560 worth of Varian Medical Systems, Inc. (NYSE:VAR) on Tuesday, March 6.

Analysts expect Varian Medical Systems, Inc. (NYSE:VAR) to report $1.03 EPS on April, 25 after the close.They anticipate $0.14 EPS change or 15.73 % from last quarter’s $0.89 EPS. VAR’s profit would be $94.04M giving it 30.44 P/E if the $1.03 EPS is correct. After having $1.06 EPS previously, Varian Medical Systems, Inc.’s analysts see -2.83 % EPS growth. The stock decreased 1.33% or $1.69 during the last trading session, reaching $125.4. About 731,568 shares traded. Varian Medical Systems, Inc. (NYSE:VAR) has risen 32.94% since April 24, 2017 and is uptrending. It has outperformed by 21.39% the S&P500.

Varian Medical Systems, Inc. (NYSE:VAR) Ratings Coverage

Among 8 analysts covering Varian Medical Systems (NYSE:VAR), 3 have Buy rating, 2 Sell and 3 Hold. Therefore 38% are positive. Varian Medical Systems had 11 analyst reports since October 25, 2017 according to SRatingsIntel. The firm has “Hold” rating by Robert W. Baird given on Thursday, January 25. The firm earned “Hold” rating on Thursday, November 30 by RBC Capital Markets. JP Morgan maintained Varian Medical Systems, Inc. (NYSE:VAR) on Thursday, January 25 with “Neutral” rating. The rating was maintained by Jefferies on Wednesday, October 25 with “Buy”. The firm has “Buy” rating given on Thursday, January 25 by Barrington. The stock of Varian Medical Systems, Inc. (NYSE:VAR) has “Buy” rating given on Thursday, January 25 by Citigroup. The firm earned “Sell” rating on Thursday, January 25 by Goldman Sachs. The firm has “Hold” rating by RBC Capital Markets given on Thursday, January 25. The company was maintained on Monday, October 30 by Citigroup. The firm earned “Hold” rating on Thursday, October 26 by Robert W. Baird.

Varian Medical Systems, Inc. designs, makes, sells, and services medical devices and software products for treating cancer and other medical conditions worldwide. The company has market cap of $11.45 billion. It operates through two divisions, Oncology Systems and Imaging Components. It has a 94.21 P/E ratio. The Oncology Systems segment provides hardware and software products for treating cancer with radiotherapy, fixed field intensity-modulated radiation therapy, image-guided radiation therapy, volumetric modulated arc therapy, stereotactic radiosurgery, stereotactic body radiotherapy, and brachytherapy.

Varian Medical Systems, Inc. (NYSE:VAR) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: